Adenosine analogue reduces spinal cord reperfusion injury in a time-dependent fashion.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Surgery

• Publication date

  2001-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1067/MSY.2001.115838PMID 11490354
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A(2A) receptor agonists.

  2001cited by this paper
• Cyclic AMP‐dependent inhibition of human neutrophil oxidative activity by substituted 2‐propynylcyclohexyl adenosine A2A receptor agonists

  2001cited by this paper
• Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection.

  2001cited by this paper
• Design, synthesis, and evaluation of novel A2A adenosine receptor agonists.

  2001cited by this paper
• Fas Receptor and Neuronal Cell Death after Spinal Cord Ischemia

  2000cited by this paper
• The role of inflammation in vascular diseases

  2000cited by this paper
• Adenosine and selective A(2A) receptor agonists reduce ischemia/reperfusion injury of rat liver mainly by inhibiting leukocyte activation.

  2000cited by this paper
• Design, synthesis, and evaluation of novel adenosine A2A receptor agonists

  2000cited by this paper
• Spinal cord protection during aortic cross-clamping using retrograde venous perfusion.

  1999cited by this paper
• Preservation of intercostal arteries during thoracoabdominal aortic aneurysm surgery: a retrospective study.

  1999cited by this paper
• A2B Adenosine and P2Y2 Receptors Stimulate Mitogen-activated Protein Kinase in Human Embryonic Kidney-293 Cells

  1999cited by this paper
• Delayed selective motor neuron death and fas antigen induction after spinal cord ischemia in rabbits.

  1998cited by this paper
• A physiological role of the adenosine A3 receptor: sustained cardioprotection.

  1998cited by this paper
• Regarding "Observations on delayed neurologic deficit after thoracoabdominal aortic aneurysm repair".

  1998cited by this paper
• Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release.

  1997cited by this paper
• Adenosine A2 receptor activation attenuates reperfusion injury by inhibiting neutrophil accumulation, superoxide generation and coronary endothelial adherence.

  1997cited by this paper
• Adenosine inhibits cytokine release and expression of adhesion molecules by activated human endothelial cells.

  1996cited by this paper
• Adenosine activates A2 receptors to inhibit neutrophil adhesion and injury to isolated cardiac myocytes.

  1995cited by this paper
• Complete prevention of postischemic spinal cord injury by means of regional infusion with hypothermic saline and adenosine.

  1994cited by this paper
• Propentofylline enhancement of the actions of adenosine on neutrophil leukocytes.

  1994cited by this paper
• Moderate hypothermia, with partial bypass and segmental sequential repair for thoracoabdominal aortic aneurysm.

  1994cited by this paper
• Adenosine, an endogenous anti-inflammatory agent.

  1994cited by this paper
• Thoracoabdominal aneurysm repair: a representative experience.

  1992cited by this paper
• Selective deep hypothermia of the spinal cord prevents paraplegia after aortic cross-clamping in the dog model.

  1992cited by this paper
• Changes in cerebrospinal fluid pressure and spinal cord perfusion pressure prior to cross-clamping of the thoracic aorta in humans.

  1991cited by this paper
• The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively.

  1990cited by this paper
• Thoracoabdominal aortic aneurysms: preoperative and intraoperative factors determining immediate and long-term results of operations in 605 patients.

  1986cited by this paper

• GPCRs in traumatic brain or spinal injury.

  2025cites this paper
• Neuromonitoring during descending aorta procedures.

  2022cites this paper
• Activation of AMP-activated protein kinase α1 mediates mislocalization of TDP-43 in amyotrophic lateral sclerosis.

  2015cites this paper
• Attenuation of Spinal Cord Injury After Thoracic Aortic Cross-Clamping Agonist for 2A Comparison of Systemic and Retrograde Delivery of Adenosine A

  2013cites this paper
• Adenosine, inflammation pathways and therapeutic challenges.

  2011cites this paper
• Adenosine receptors and neurological disease: neuroprotection and neurodegeneration.

  2009cites this paper
• Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells

  2008cites this paper
• Adenosine A 2 A receptor antagonists : blockade of adenosinergic effects and T regulatory cells

  2008cites this paper
• Early adenosine receptor activation ameliorates spinal cord reperfusion injury

  2008cites this paper
• The effects of prophylactic zinc and melatonin application on experimental spinal cord ischemia–reperfusion injury in rabbits: experimental study

  2007cites this paper
• A comparison of adenosine A2A agonism and methylprednisolone in attenuating neuronal damage and improving functional outcome after experimental traumatic spinal cord injury in rabbits.

  2006cites this paper
• Comparison of systemic and retrograde delivery of adenosine A2A agonist for attenuation of spinal cord injury after thoracic aortic cross-clamping.

  2006cites this paper
• Optimization of a mouse locomotor rating system to evaluate compression-induced spinal cord injury: correlation of locomotor and morphological injury indices.

  2006cites this paper
• Functional and cytoarchitectural spinal cord protection by ATL-146e after ischemia/reperfusion is mediated by adenosine receptor agonism.

  2006cites this paper
• Comparison of Systemic and Retrograde Delivery of Adenosine A 2A Agonist for Attenuation of Spinal Cord Injury After Thoracic Aortic

  2006cites this paper
• Adenosine A2A receptor agonist improves cardiac dysfunction from pulmonary ischemia-reperfusion injury.

  2005cites this paper
• Building a better fluid for emergency resuscitation of traumatic brain injury.

  2004cites this paper
• The evolution of ischemic spinal cord injury in function, cytoarchitecture, and inflammation and the effects of adenosine A2A receptor activation.

  2004cites this paper
• The effects of tyrphostine Ag 556 on experimental spinal cord ischemia reperfusion injury.

  2004cites this paper
• Physiological control of immune response and inflammatory tissue damage by hypoxia-inducible factors and adenosine A2A receptors.

  2004cites this paper
• Targeting hypoxia--A(2A) adenosine receptor-mediated mechanisms of tissue protection.

  2004cites this paper
• Adenosine A2A analogue reduces long-term neurologic injury after blunt spinal trauma.

  2004cites this paper
• Novel resuscitation strategy for pulmonary contusion after severe chest trauma.

  2003cites this paper
• Use of the A(2A) adenosine receptor as a physiological immunosuppressor and to engineer inflammation in vivo.

  2003cites this paper
• Participation of adenosine receptors in neuroprotection.

  2003cites this paper
• The role of pharmacology in spinal cord protection during thoracic aortic reconstruction.

  2003cites this paper
• Adenosine A2A agonist reduces paralysis after spinal cord ischemia: correlation with A2A receptor expression on motor neurons.

  2002cites this paper
• Adenosine A2A analogue improves neurologic outcome after spinal cord trauma in the rabbit.

  2002cites this paper
• Adenosine receptors in the nervous system: pathophysiological implications.

  2002cites this paper
• An adenosine A2A agonist, ATL-146e, reduces paralysis and apoptosis during rabbit spinal cord reperfusion.

  2001cites this paper
• Systemic adenosine A2A agonist ameliorates ischemic reperfusion injury in the rabbit spinal cord.

  2001cites this paper